Monitoring viral decontamination procedures with green fluorescent protein-expressing adenovirus

Analytical Biochemistry

Volumn 355, Issue 2, 2006, Pages 310-312

  Losert, Annemarie ^a   Mauritz, Ilse ^a   Erlach, Natascha ^a   Herbacek, Irene ^a   Schulte Hermann, Rolf ^a   Holzmann, Klaus ^a   Grusch, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

GREEN FLUORESCENT PROTEIN;

CHEMISTRY;

GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; FLUORESCENCE ACTIVATED CELL SORTING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 33746274740     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.04.034     Document Type: Article

References (13)

1. Hitt M.M., Addison C.L., and Graham F.L. Human adenovirus vectors for gene transfer into mammalian cells. Adv. Pharmacol. 40 (1997) 137-206
2. Maheshwari G., Jannat R., McCormick L., and Hsu D. Thermal inactivation of adenovirus type 5. J. Virol. Methods 118 (2004) 141-146
3. Klein H.G. Pathogen inactivation technology: cleansing the blood supply. J. Intern. Med. 257 (2005) 224-237
4. Celis P., and Silvester G. European regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies, and plasma derived medicinal products. Dev. Biol. (Basel) 118 (2004) 3-10
5. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95 (1998) 2509-2514
6. Jannat R., Hsu D., and Maheshwari G. Inactivation of adenovirus type 5 by caustics. Biotechnol. Prog. 21 (2005) 446-450
7. Ugai H., Watanabe S., Suzuki E., Tsutsui-Nakata H., Yokoyama K.K., and Murata T. Stability of a recombinant adenoviral vector: optimization of conditions for storage, transport, and delivery. Jpn. J. Cancer Res. 93 (2002) 598-603
8. Gordon Y.J., Gordon R.Y., Romanowski E., and Araullo-Cruz T.P. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 100 (1993) 1835-1840
9. Nwachuku N., Gerba C.P., Oswald A., and Mashadi F.D. Comparative inactivation of adenovirus serotypes by UV light disinfection. Appl. Environ. Microbiol. 71 (2005) 5633-5636
10. Nyberg-Hoffman C., and Aguilar-Cordova E. Instability of adenoviral vectors during transport and its implication for clinical studies. Nat. Med. 5 (1999) 955-957
11. Boschetti N., Wyss K., Mischler A., Hostettler T., and Kempf C. Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals 31 (2003) 181-185
12. Obenauer-Kutner L.J., Ihnat P.M., Yang T.Y., Dovey-Hartman B.J., Balu A., Cullen C., Bordens R.W., and Grace M.J. The use of field emission scanning electron microscopy to assess recombinant adenovirus stability. Hum. Gene Ther. 13 (2002) 1687-1696
13. McCormick L., and Maheshwari G. Inactivation of adenovirus types 5 and 6 by Virkon S. Antiviral Res. 64 (2004) 27-33